Development of a Core Set of Patient-Reported Outcomes for Population-Based Cancer Survivorship Research: Protocol for an Australian Consensus Study

被引:3
作者
Ramsey, Imogen [1 ,2 ]
Corsini, Nadia [1 ,2 ]
Hutchinson, Amanda D. [3 ]
Marker, Julie [4 ]
Eckert, Marion [1 ,2 ]
机构
[1] Univ South Australia, Sch Nursing, Rosemary Bryant AO Res Ctr, City East Campus,North Terrace, Adelaide, SA 5001, Australia
[2] Univ South Australia, Midwifery & UniSA Canc Res Inst, City East Campus,North Terrace, Adelaide, SA 5001, Australia
[3] Univ South Australia, Sch Psychol Social Work & Social Policy, Adelaide, SA, Australia
[4] Canc Voices South Australia, Adelaide, SA, Australia
来源
JMIR RESEARCH PROTOCOLS | 2020年 / 9卷 / 01期
关键词
cancer survivorship; quality of life; patient-reported outcomes; core outcome set; Delphi study; consensus; DELPHI;
D O I
10.2196/14544
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Core outcome sets seek to improve the consistency and quality of research by providing agreed-upon recommendations regarding what outcomes should be measured as a minimum for a population and setting. The problems arising from a lack of outcome standardization in population-based cancer survivorship research indicate the need for agreement on a core set of patient-reported outcomes (PROs) to enhance data quality, consistency, and comparability. Objective: This study aims to identify a core set of PROs, representing the most important issues impacting on cancer survivors' long-term health, functioning and quality of life, to inform population-based research on cancer survivorship. Methods: In Phase I, a list of all potentially important outcomes will be generated through focus group discussions with cancer survivors and a review of measures for assessing quality of life in cancer survivorship. The consolidated list will be advanced to Phase II, where a stakeholder consensus process will be conducted with national experts in cancer survivorship to refine and prioritize the outcomes into a core outcome set. The process will consist of a two-round Delphi survey and a consensus meeting. Cancer survivors, oncology health care professionals, and potential end users of the core outcome set with expertise in cancer survivorship research or policy will be invited to participate. In Phase III, recommended measures for assessment of the core outcome set will be selected with advice from experts on the assessment, analysis, and interpretation of PROs. Results: As of April 2019, data collection for Phase I is complete and data analysis is underway. These data will inform the list of outcomes to be advanced into Phase II. Recruitment for Phase II will commence in June 2019, and it is anticipated that it will take 6 months to complete the three-step consensus process and identify a provisional core outcome set. The study results are expected to be published in early 2020. Conclusions: Expert consensus-driven recommendations on outcome measurement will facilitate the inclusion of survivorship outcomes considered important by cancer survivors and health professionals in future research. Adoption of the core outcome set will enable comparison and synthesis of evidence across studies and enhance the quality of PRO data collected in cancer survivorship research, particularly when applied to address macro-level questions.
引用
收藏
页数:8
相关论文
共 36 条
  • [11] Recommended Patient-Reported Core Set of Symptoms and Quality-of-Life Domains to Measure in Ovarian Cancer Treatment Trials
    Donovan, Kristine A.
    Donovan, Heidi S.
    Cella, David
    Gaines, Martha E.
    Penson, Richard T.
    Plaxe, Steven C.
    von Gruenigen, Vivian E.
    Bruner, Deborah Watkins
    Reeve, Bryce B.
    Wenzel, Lari
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (07):
  • [12] Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathology
    Eubank, Breda H.
    Mohtadi, Nicholas G.
    Lafave, Mark R.
    Wiley, J. Preston
    Bois, Aaron J.
    Boorman, Richard S.
    Sheps, David M.
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2016, 16
  • [13] Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
    Ferlay, Jacques
    Soerjomataram, Isabelle
    Dikshit, Rajesh
    Eser, Sultan
    Mathers, Colin
    Rebelo, Marise
    Parkin, Donald Maxwell
    Forman, David
    Bray, Freddie
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) : E359 - E386
  • [14] The COMET Initiative database: progress and activities from 2011 to 2013
    Gargon, Elizabeth
    Williamson, Paula R.
    Altman, Douglas G.
    Blazeby, Jane M.
    Clarke, Mike
    [J]. TRIALS, 2014, 15
  • [15] Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set
    Geerse, O. P.
    Wynia, K.
    Kruijer, M.
    Schotsman, M. J.
    Hiltermann, T. J. N.
    Berendsen, A. J.
    [J]. SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 567 - 574
  • [16] Comparing face-to-face meetings, nominal groups, Delphi and prediction markets on an estimation task
    Graefe, Andreas
    Armstrong, J. Scott
    [J]. INTERNATIONAL JOURNAL OF FORECASTING, 2011, 27 (01) : 183 - 195
  • [17] Greenhalgh J., 2017, NIHR Journals Library, V5, DOI DOI 10.3310/HSDR05020
  • [18] GRADE guidelines 6. Rating the quality of evidence-imprecision
    Guyatt, Gordon H.
    Oxman, Andrew D.
    Kunz, Regina
    Brozek, Jan
    Alonso-Coello, Pablo
    Ring, David
    Devereaux, P. J.
    Montori, Victor M.
    Freyschuss, Bo
    Vist, Gunn
    Jaeschke, Roman
    Williams, John W., Jr.
    Murad, Mohammad Hassan
    Sinclair, David
    Falck-Ytter, Yngve
    Meerpohl, Joerg
    Whittington, Craig
    Thorlund, Kristian
    Andrews, Jeff
    Schuenemann, Holger J.
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2011, 64 (12) : 1283 - 1293
  • [19] Enhancing rigour in the Delphi technique research
    Hasson, Felicity
    Keeney, Sinead
    [J]. TECHNOLOGICAL FORECASTING AND SOCIAL CHANGE, 2011, 78 (09) : 1695 - 1704
  • [20] Core Outcome Set-STAndards for Development: The COS-STAD recommendations
    Kirkham, Jamie J.
    Davis, Katherine
    Altman, Douglas G.
    Blazeby, Jane M.
    Clarke, Mike
    Tunis, Sean
    Williamson, Paula R.
    [J]. PLOS MEDICINE, 2017, 14 (11):